MGC026
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MGC026, covering 2026-02-05 to 2026-02-05. Get the full timeline:
Most recent: Clinical Trial Update: A Study of MGC026 in Participants With Advanced Solid Tumors [Phase 1]